| scholarly article | Q13442814 |
| P50 | author | Anna Dominiczak | Q4766963 |
| Andrea Degasperi | Q55095173 | ||
| Ian P Salt | Q56876361 | ||
| Michael P. Murphy | Q37391317 | ||
| Christian Delles | Q43096626 | ||
| P2093 | author name string | William H Miller | |
| Angela Logan | |||
| Carlene A Hamilton | |||
| Hagar A Ibrahim | |||
| Jane A Dymott | |||
| Ruth M Mackenzie | |||
| P2860 | cites work | Effects of nitric oxide and superoxide on relaxation in human artery and vein | Q56970954 |
| Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries | Q73762643 | ||
| Possible involvement of the alpha1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. | Q44802854 | ||
| Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis | Q44954085 | ||
| Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species | Q44987425 | ||
| AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. | Q46037787 | ||
| Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase | Q46359191 | ||
| Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells | Q46523954 | ||
| Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells | Q46738375 | ||
| Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells | Q46870176 | ||
| AMPKalpha1 regulates the antioxidant status of vascular endothelial cells | Q47801068 | ||
| The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress | Q24633606 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management | Q28218905 | ||
| Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools | Q28241521 | ||
| Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase | Q28567006 | ||
| Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage | Q29616101 | ||
| Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
| 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? | Q29618095 | ||
| AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes | Q34059872 | ||
| Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase | Q34236772 | ||
| Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins | Q34333678 | ||
| Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. | Q34438345 | ||
| Mitochondria as signaling organelles in the vascular endothelium | Q34600173 | ||
| Early determinants of H2O2-induced endothelial dysfunction | Q35070086 | ||
| Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix | Q35549813 | ||
| Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio | Q35888893 | ||
| Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. | Q36732931 | ||
| Mitochondrial dysfunction in atherosclerosis. | Q36749083 | ||
| Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation | Q37234346 | ||
| AMPK: a key regulator of energy balance in the single cell and the whole organism. | Q37249357 | ||
| Activation and signaling by the AMP-activated protein kinase in endothelial cells | Q37553770 | ||
| Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells | Q40331177 | ||
| Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells | Q41901421 | ||
| Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase | Q42075557 | ||
| AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633 | Q42582636 | ||
| The regulation of AMP-activated protein kinase by H(2)O(2). | Q42825708 | ||
| Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase | Q43952389 | ||
| Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
| Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. | Q44489729 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| patient | Q181600 | ||
| endothelium | Q111140 | ||
| reactive oxygen species | Q424361 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 403-411 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetes | |
| P478 | volume | 124 |
| Q35977945 | Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake |
| Q38501183 | Antioxidant Therapy: Is it your Gateway to Improved Cardiovascular Health? |
| Q37101614 | Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures |
| Q37341923 | Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice |
| Q51760160 | Dealing with Stress: Defective Metabolic Adaptation in Chronic Obstructive Pulmonary Disease Pathogenesis. |
| Q42848863 | Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria |
| Q28505980 | HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth |
| Q35795868 | Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner |
| Q64976796 | Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease |
| Q36219290 | Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells |
| Q46255692 | Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production. |
| Q36979168 | Mitochondria and endothelial function |
| Q33600464 | Mitochondria, endothelial cell function, and vascular diseases |
| Q39400621 | Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. |
| Q39223398 | Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms. |
| Q91982108 | Mitochondrial Dysfunction and Diabetes: Is Mitochondrial Transfer a Friend or Foe? |
| Q28388387 | Mitochondrial hormesis and diabetic complications |
| Q42500471 | Mitochondrial respiration is sensitive to cytoarchitectural breakdown |
| Q38692444 | Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies. |
| Q35148462 | Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. |
| Q94594448 | New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models |
| Q95651535 | Nuclear-mitochondrial communication involving miR-181c plays an important role in cardiac dysfunction during obesity |
| Q37008888 | Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals |
| Q42589408 | Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. |
| Q38703924 | Pro-survival redox signalling in progesterone-mediated retinal neuroprotection |
| Q54393648 | Prolonged AMP-activated protein kinase induction impairs vascular functions. |
| Q58731834 | RPS3A positively regulates the mitochondrial function of human periaortic adipose tissue and is associated with coronary artery diseases |
| Q38846534 | Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm |
| Q38873909 | Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy |
| Q88985401 | Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy |
Search more.